Source register
Every claim needs
the right context.
Open a record to find the source and its citing articles. Check which product, use and date it actually covers.
CoreAge Rx: Non-Hormonal Menopause, oral paroxetine offerChecked 2026-09-27
Provider product information
Checked 2026-09-27. Labels and commercial information can change.
DailyMed: Brisdelle paroxetine capsules, updated April 28, 2025Checked 2026-09-27
Exact product labeling
Checked 2026-09-27. Labels and commercial information can change.
- CoreAge Rx nonhormonal menopause review: paroxetine and the actual treatment goal
- Best nonhormonal menopause care options to compare, with clear limits
- Midi nonhormonal menopause review: what a care-plan visit includes
- Evernow nonhormonal menopause review: medicine choices and ongoing care
- Non-estrogen medication for hot flashes: understand the treatment families
- Prepare a nonhormonal menopause visit around the result that matters to you
FDA: Understanding unapproved use of approved drugsChecked 2026-09-27
Regulator explanation
Checked 2026-09-27. Labels and commercial information can change.
FDA: Lynkuet drug trials snapshot, approved October 24, 2025Checked 2026-09-27
Regulator approval and trial summary
Checked 2026-09-27. Labels and commercial information can change.
- CoreAge Rx nonhormonal menopause review: paroxetine and the actual treatment goal
- Best nonhormonal menopause care options to compare, with clear limits
- Midi nonhormonal menopause review: what a care-plan visit includes
- Non-estrogen medication for hot flashes: understand the treatment families
- Lynkuet vs Veozah: a guide to comparing the evidence
FDA: Veozah serious liver injury safety communicationChecked 2026-09-27
Regulator safety communication
Checked 2026-09-27. Labels and commercial information can change.
DailyMed: Veozah prescribing information, updated February 26, 2026Checked 2026-09-27
Exact product labeling
Checked 2026-09-27. Labels and commercial information can change.
- Best nonhormonal menopause care options to compare, with clear limits
- Midi nonhormonal menopause review: what a care-plan visit includes
- Evernow nonhormonal menopause review: medicine choices and ongoing care
- Non-estrogen medication for hot flashes: understand the treatment families
- Fezolinetant and liver monitoring: understand the responsibility behind the tests
- Prepare a nonhormonal menopause visit around the result that matters to you
The Menopause Society: 2023 nonhormone therapy position statement, accessible abstractChecked 2026-09-27
Medical society position statement abstract
Checked 2026-09-27. Labels and commercial information can change.
Midi: Menopause care and hormonal/nonhormonal optionsChecked 2026-09-27
Provider service information
Checked 2026-09-27. Labels and commercial information can change.
Midi: Pricing and insuranceChecked 2026-09-27
Provider pricing and access
Checked 2026-09-27. Labels and commercial information can change.
Midi: Additional Medicare and Medicaid access conditionsChecked 2026-09-27
Provider access terms
Checked 2026-09-27. Labels and commercial information can change.
Midi: Non-Hormonal Treatment for Menopause, October 30, 2025Checked 2026-09-27
Provider educational article
Checked 2026-09-27. Labels and commercial information can change.
Evernow: Paroxetine service and product FAQChecked 2026-09-27
Provider product information
Checked 2026-09-27. Labels and commercial information can change.
Evernow: Veozah service and safety summaryChecked 2026-09-27
Provider product information
Checked 2026-09-27. Labels and commercial information can change.
Evernow: Nonhormonal treatment category and FAQChecked 2026-09-27
Provider service information
Checked 2026-09-27. Labels and commercial information can change.
Evernow: Care formats, membership prices, insurance and pharmacy FAQChecked 2026-09-27
Provider terms and pricing
Checked 2026-09-27. Labels and commercial information can change.
Bayer: Lynkuet US prescribing information, revised August 2026Checked 2026-09-27
Current US prescription product labeling
Checked 2026-09-27. Labels and commercial information can change.
The Menopause Society: 2023 nonhormone therapy position statementChecked 2026-09-27
Medical society evidence review
Checked 2026-09-27. Labels and commercial information can change.
The Menopause Society: Hot FlashesChecked 2026-09-27
Medical society patient information
Checked 2026-09-27. Labels and commercial information can change.
FDA: Menopause treatment questionsChecked 2026-09-27
Federal regulator patient information
Checked 2026-09-27. Labels and commercial information can change.
Alloy: ParoxetineChecked 2026-09-29
Official 10 mg offer; FDA-approved wording is not independently applied to the advertised preparation, and one-month/three-month supply wording remains unresolved
Checked 2026-09-29. Labels and commercial information can change.
DailyMed: Brisdelle paroxetine capsulesChecked 2026-09-29
Exact oral 7.5 mg capsule label updated April 28, 2025; approved vasomotor indication and warnings remain product-specific, not Alloy 10 mg authentication
Checked 2026-09-29. Labels and commercial information can change.
FDA: Understanding unapproved use of approved drugsChecked 2026-09-29
Federal explanation distinguishing an approved medicine from an unapproved use; not a personal recommendation
Checked 2026-09-29. Labels and commercial information can change.
- Alloy nonhormonal menopause review: the product behind the approval claim
- Pandia Health nonhormonal menopause review: two named options within a larger care offer
- Joi nonhormonal menopause review: a relevant clinic with an unresolved treatment menu
- FOLX nonhormonal menopause review: clinical care, community and membership are separate
- Maven Clinic nonhormonal menopause review: what the two-visit package includes
Alloy: terms of useChecked 2026-09-28
Dated platform terms; subscription and shipment cancellation deadlines, first-shipment refund conditions and service-fee exclusions kept separate
Checked 2026-09-28. Labels and commercial information can change.
Gennev: Symptoms and TreatmentChecked 2026-09-29
Official clinical service and treatment categories; exact nonhormonal medicine selection unconfirmed
Checked 2026-09-29. Labels and commercial information can change.
The Menopause Society: 2023 nonhormone therapy position statementChecked 2026-09-29
PubMed primary professional abstract; vasomotor-symptom evidence categories, dated 2023 and not provider-specific efficacy or later-drug approval
Checked 2026-09-29. Labels and commercial information can change.
- Gennev nonhormonal menopause review: separate the doctor’s proposal from lifestyle support
- Stella nonhormonal menopause review: clinical treatment and app support have different roles
- Joi nonhormonal menopause review: a relevant clinic with an unresolved treatment menu
- FOLX nonhormonal menopause review: clinical care, community and membership are separate
- Maven Clinic nonhormonal menopause review: what the two-visit package includes
Gennev: insurance and pricingChecked 2026-09-28
Dated provider fee table and coverage process; doctor/dietitian initial/follow-up costs are separate from pharmacy charges
Checked 2026-09-28. Labels and commercial information can change.
MyMenopauseRx: TreatmentsChecked 2026-09-29
Official clinical offer names fezolinetant and other treatment categories; no personal prescription or outcome confirmed
Checked 2026-09-29. Labels and commercial information can change.
DailyMed: Veozah fezolinetant tabletsChecked 2026-09-29
Exact label revised February 2026 with boxed hepatotoxicity warning, required clinical monitoring and product-specific contraindications; not personal clearance
Checked 2026-09-29. Labels and commercial information can change.
MyMenopauseRx: telehealth FAQChecked 2026-09-28
Dated provider visit/pharmacy/refill/coverage/cancellation record; personal prescription, generic identity and clinical decisions remain unverified
Checked 2026-09-28. Labels and commercial information can change.
Pandia Health: Menopause careChecked 2026-09-29
Official current clinical/pharmacy menu includes paroxetine and Veozah; pharmacy stock, selected medicine and malformed three-month billed amount unresolved
Checked 2026-09-29. Labels and commercial information can change.
Stella US: Menopause careChecked 2026-09-29
US clinical offer, age/access and payment information; nonhormonal category and coaching do not identify a particular medicine
Checked 2026-09-29. Labels and commercial information can change.
FDA: Drug Trials Snapshot, LynkuetChecked 2026-09-29
Original FDA approval and trial-population summary; not a complete current label or provider offering
Checked 2026-09-29. Labels and commercial information can change.
DailyMed: Lynkuet elinzanetant capsulesChecked 2026-09-29
Exact current label revised August 2026; product-specific warnings and use, not a claim any reviewed clinic supplies it
Checked 2026-09-29. Labels and commercial information can change.
Wisp: Non-Hormonal Vaginal MoisturizerChecked 2026-09-29
Official specific local-dryness offer and latex-condom caution; marketing does not establish vasomotor efficacy or a complete formulation
Checked 2026-09-29. Labels and commercial information can change.
Wisp: Menopause Consult OnlineChecked 2026-09-29
Official clinical offer and separately billed local-pharmacy medicines; exact systemic nonhormonal medicine offer unconfirmed
Checked 2026-09-29. Labels and commercial information can change.
Wisp: terms of useChecked 2026-09-28
Dated platform transaction terms; prescription renewal review, 48-hour cancellation and discretionary product remedies; not individual legal advice
Checked 2026-09-28. Labels and commercial information can change.
Joi + Blokes: Clinical care overviewChecked 2026-09-29
Official menopause clinical service and coaching roles; no specific nonhormonal vasomotor prescription confirmed
Checked 2026-09-29. Labels and commercial information can change.
Joi + Blokes: Hormone replacement therapyChecked 2026-09-29
Hormonal program prices and quarterly commitments; not a confirmed nonhormonal medicine menu or quote
Checked 2026-09-29. Labels and commercial information can change.
FOLX: Perimenopause and menopause supportChecked 2026-09-29
Official LGBTQIA+ clinical service description with nonhormonal medication category; specific product and indication unconfirmed
Checked 2026-09-29. Labels and commercial information can change.
FOLX: What can a clinician help with?Checked 2026-09-29
Official clinical service, published visit charges and appointment cancellation terms; not personal availability
Checked 2026-09-29. Labels and commercial information can change.
FOLX: What is a membership?Checked 2026-09-29
Official membership explainer dated August 2023 as currently accessible; monthly versus annual billed amounts, services extra
Checked 2026-09-29. Labels and commercial information can change.
FOLX: Membership cancellation policyChecked 2026-09-29
Official membership notice, annual account control timing, no membership refunds and remaining bills; separate appointment cancellation terms
Checked 2026-09-29. Labels and commercial information can change.
Maven: Hormone Care EssentialsChecked 2026-09-29
Direct clinical offer with stated nonhormonal medicine families and one-time care package; individual eligibility, selected drug and refund outcome unconfirmed
Checked 2026-09-29. Labels and commercial information can change.
Maven: Terms of UseChecked 2026-09-29
Official platform terms updated September 23, 2026; independent practitioner roles and enterprise distinctions, not a complete selected Hormone Care refund agreement
Checked 2026-09-29. Labels and commercial information can change.
Allara: menopause insurance landing pageChecked 2026-09-29
Service and plan-price record; broader Complete Care scope
Checked 2026-09-29. Labels and commercial information can change.
Allara: care program and service FAQsChecked 2026-09-29
Actual menopause care scope; state and program distinctions
Checked 2026-09-29. Labels and commercial information can change.
Allara help center: program costsChecked 2026-09-29
Official linked support record; self-pay, insurance and excluded charges
Checked 2026-09-29. Labels and commercial information can change.
Hello Alpha: menopause treatmentChecked 2026-09-29
Clinical service page; local estrogen and systemic nonhormonal categories need separation
Checked 2026-09-29. Labels and commercial information can change.
Mass General Brigham: Menopause and Midlife ClinicChecked 2026-09-29
Regional clinical program and appointment contacts; no exact drug menu verified
Checked 2026-09-29. Labels and commercial information can change.
Penn Medicine: menopause and postmenopause careChecked 2026-09-29
Clinical service; current new center focus on cancer survivors and previvors
Checked 2026-09-29. Labels and commercial information can change.
Myla Health: consultation servicesChecked 2026-09-29
UK private clinical service; NHS prescribing remains separate
Checked 2026-09-29. Labels and commercial information can change.
Myla Health: patient FAQsChecked 2026-09-29
UK location, billing, cancellation and investigation responsibility conditions
Checked 2026-09-29. Labels and commercial information can change.
Newson Clinic: consultationsChecked 2026-09-29
UK hormone and nonhormonal consultation scope; exact drug unconfirmed
Checked 2026-09-29. Labels and commercial information can change.
Newson Clinic: current services and displayed feesChecked 2026-09-29
Commercial service and fee record; no independent efficacy claim
Checked 2026-09-29. Labels and commercial information can change.
Hello Alpha: terms of useChecked 2026-09-29
Commercial terms; automatic renewal, separate refill cancellation and refund limits
Checked 2026-09-29. Labels and commercial information can change.
Hello Alpha: membershipChecked 2026-09-29
Published monthly plan and visit units; separate prescription charges
Checked 2026-09-29. Labels and commercial information can change.
Allara: terms and conditionsChecked 2026-09-29
Subscription cancellation and discretionary refund conditions; no legal advice
Checked 2026-09-29. Labels and commercial information can change.
Allara: telehealth informed consentChecked 2026-09-29
Initial monthly commitment and ongoing subscription terms
Checked 2026-09-29. Labels and commercial information can change.
Allara: how care worksChecked 2026-09-29
Broader weight-care page with different Complete Care and nutrition prices; selected quote unresolved
Checked 2026-09-29. Labels and commercial information can change.
Myla Health: prices effective April 1, 2026Checked 2026-09-29
UK visit and prescription-administration fees, excluding actual medicine
Checked 2026-09-29. Labels and commercial information can change.
Newson Clinic: prices-page extractionChecked 2026-09-29
Current extraction lacks a full fee table; home-page prices separately sourced
Checked 2026-09-29. Labels and commercial information can change.
Penn Medicine: contact and schedulingChecked 2026-09-29
Appointment contact hours; no personal availability or price established
Checked 2026-09-29. Labels and commercial information can change.
The Menopause Society: 2023 nonhormone therapy position statementChecked 2026-09-29
Professional evidence review; predates Lynkuet approval
Checked 2026-09-29. Labels and commercial information can change.
- Allara nonhormonal menopause review: symptom care, nutrition and plan-price differences
- Hello Alpha nonhormonal menopause review: separate the symptom menu from the prescription
- Myla Health nonhormonal menopause review: a UK discussion with explicit follow-up boundaries
- Newson Clinic nonhormonal menopause review: what the consultation page actually promises
- Mass General Brigham nonhormonal menopause review: coordinating a regional symptom assessment
- Penn Medicine nonhormonal menopause review: what needs current confirmation
FDA: unapproved uses of approved drugsChecked 2026-09-29
Regulator explanation; product and indication scope
Checked 2026-09-29. Labels and commercial information can change.
FDA: menopause treatment categoriesChecked 2026-09-29
Regulator patient overview; hormone versus nonhormone distinction
Checked 2026-09-29. Labels and commercial information can change.
FDA: Lynkuet Drug Trials SnapshotChecked 2026-09-29
Original October 2025 approval evidence; current safety label separately reviewed
Checked 2026-09-29. Labels and commercial information can change.
Veozah (fezolinetant) US prescribing informationChecked 2026-09-29
Exact official DailyMed label. Revised February 2026; boxed hepatotoxicity warning; same-day official HTML record reviewed with original timestamp
Checked 2026-09-29. Labels and commercial information can change.
Lynkuet (elinzanetant) US prescribing informationChecked 2026-09-29
Exact official DailyMed label. Text revised August 2026; page metadata says updated June 16, 2026; same-day official HTML record reviewed with original timestamp
Checked 2026-09-29. Labels and commercial information can change.
Brisdelle (paroxetine) US prescribing informationChecked 2026-10-21
Exact official DailyMed label. Revised April 2025; exact 7.5 mg capsule, not general paroxetine tablets; same-day official HTML record reviewed with original timestamp
Checked 2026-10-21. Labels and commercial information can change.
- Brisdelle review: the specific paroxetine capsule behind a hot-flash approval
- Hello Alpha nonhormonal menopause review: separate the symptom menu from the prescription
- Mass General Brigham nonhormonal menopause review: coordinating a regional symptom assessment
- Penn Medicine nonhormonal menopause review: what needs current confirmation
- Paroxetine’s Menopause Trials: Reading Hot-Flash and Sleep Outcomes Together
- SKYLIGHT 1: Fezolinetant’s Symptom Effects and Evolving Liver-Safety Evidence
Duke Health — MenopauseChecked 2026-09-29
Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.
Checked 2026-09-29. Labels and commercial information can change.
Cleveland Clinic — Menopause TreatmentChecked 2026-09-29
Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.
Checked 2026-09-29. Labels and commercial information can change.
Mayo Clinic — Menopause and Women’s Sexual Health ClinicChecked 2026-09-29
Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.
Checked 2026-09-29. Labels and commercial information can change.
Johns Hopkins Medicine — Menopause ClinicChecked 2026-09-29
Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.
Checked 2026-09-29. Labels and commercial information can change.
Mount Sinai — MenopauseChecked 2026-09-29
Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.
Checked 2026-09-29. Labels and commercial information can change.
Northwestern Medicine — Program for MenopauseChecked 2026-09-29
Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.
Checked 2026-09-29. Labels and commercial information can change.
UCLA Health — Comprehensive Menopause Program Clinical ServicesChecked 2026-09-29
Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.
Checked 2026-09-29. Labels and commercial information can change.
Stanford Health Care — Menopause TreatmentsChecked 2026-09-29
Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.
Checked 2026-09-29. Labels and commercial information can change.
University of Utah Health — Midlife Women’s Health and Menopause ProgramChecked 2026-09-29
Official clinical service description, accessed September 29, 2026; an individual prescription, access arrangement, full price and outcome are not established. Published treatment categories are not an all-product formulary.
Checked 2026-09-29. Labels and commercial information can change.
Mount Sinai — Menopause LocationsChecked 2026-09-29
Official clinical location or appointment information, accessed September 29, 2026; regional access and preparation are distinct from medicine eligibility or monitoring.
Checked 2026-09-29. Labels and commercial information can change.
Northwestern Medicine — Center for Sexual Medicine and MenopauseChecked 2026-09-29
Official clinical location or appointment information, accessed September 29, 2026; regional access and preparation are distinct from medicine eligibility or monitoring.
Checked 2026-09-29. Labels and commercial information can change.
UCLA Health — Comprehensive Menopause Program Patient InformationChecked 2026-09-29
Official clinical location or appointment information, accessed September 29, 2026; regional access and preparation are distinct from medicine eligibility or monitoring.
Checked 2026-09-29. Labels and commercial information can change.
University of Utah Health — What to Expect at Your Midlife AppointmentChecked 2026-09-29
Official clinical location or appointment information, accessed September 29, 2026; regional access and preparation are distinct from medicine eligibility or monitoring.
Checked 2026-09-29. Labels and commercial information can change.
The 2023 nonhormone therapy position statement of The North American Menopause Society — PubMed abstractChecked 2026-09-29
Primary professional position-statement abstract, published 2023; vasomotor-symptom scope only. Full article not retrieved. Predates later drug approvals; does not evaluate these clinics or equate all forms of counseling.
Checked 2026-09-29. Labels and commercial information can change.
- Duke Health nonhormonal menopause review: define the hot-flash goal before interpreting the drug family
- Cleveland Clinic nonhormonal menopause review: hot flashes and vaginal discomfort are different goals
- Mayo Clinic nonhormonal menopause review: choose the consultation goal before naming a treatment
- Johns Hopkins nonhormonal menopause review: a coordinated assessment comes before the medication category
- Mount Sinai nonhormonal menopause review: symptom research is different from a treatment offer
- Northwestern Medicine nonhormonal menopause review: therapy roles should follow the concern
- Stanford Health Care nonhormonal menopause review: a named option still needs its own safety plan
- University of Utah Health nonhormonal menopause review: a broad care menu needs a defined outcome
FDA — Fezolinetant serious liver-injury safety communicationChecked 2026-09-29
Federal primary safety communication; the retrieved text displays the September 12, 2024 communication. Used for serious liver-risk and testing context only; current boxed warning and contraindications are separately supported by the current exact DailyMed label where discussed.
Checked 2026-09-29. Labels and commercial information can change.
- Duke Health nonhormonal menopause review: define the hot-flash goal before interpreting the drug family
- Cleveland Clinic nonhormonal menopause review: hot flashes and vaginal discomfort are different goals
- Mayo Clinic nonhormonal menopause review: choose the consultation goal before naming a treatment
- Johns Hopkins nonhormonal menopause review: a coordinated assessment comes before the medication category
- Mount Sinai nonhormonal menopause review: symptom research is different from a treatment offer
- Northwestern Medicine nonhormonal menopause review: therapy roles should follow the concern
- University of Utah Health nonhormonal menopause review: a broad care menu needs a defined outcome
FDA — Hormone Replacement Therapies Can Help Women with Bothersome Menopausal SymptomsChecked 2026-09-29
Current federal consumer overview, accessed September 29, 2026; confirms multiple approved nonhormonal therapies. Not a clinic’s formulary, a treatment protocol or proof all requested hormone-label changes are completed.
Checked 2026-09-29. Labels and commercial information can change.
- Duke Health nonhormonal menopause review: define the hot-flash goal before interpreting the drug family
- Cleveland Clinic nonhormonal menopause review: hot flashes and vaginal discomfort are different goals
- Mayo Clinic nonhormonal menopause review: choose the consultation goal before naming a treatment
- Johns Hopkins nonhormonal menopause review: a coordinated assessment comes before the medication category
- Mount Sinai nonhormonal menopause review: symptom research is different from a treatment offer
DailyMed — VEOZAH fezolinetant tablet, Astellas Pharma USChecked 2026-10-21
Exact oral product prescribing information, revised February 2026; boxed hepatotoxicity warning, all three contraindications and testing duties remain product-specific. Not evidence of individual clinic prescribing or a personal monitoring schedule.
Checked 2026-10-21. Labels and commercial information can change.
DailyMed — LYNKUET elinzanetant capsule, Bayer HealthCare PharmaceuticalsChecked 2026-09-29
Exact oral product prescribing information, internally revised August 2026 including seizure warning; displayed page update metadata June 16, 2026 is distinct. Indication and safety context only, not evidence UCLA offers this product. No insomnia approval or personal plan inferred.
Checked 2026-09-29. Labels and commercial information can change.
CoreAge Rx: shipping reference and service detailsChecked 2026-10-12
Homepage shipping reference; customer service and payment details supplied for this review, without a checkout or timed support test
Checked 2026-10-12. Labels and commercial information can change.
Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials.Checked 2026-10-21
Indexed primary study abstract
Checked 2026-10-21. Labels and commercial information can change.
Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause.Checked 2026-10-21
Indexed primary study abstract and full research article
Checked 2026-10-21. Labels and commercial information can change.
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study.Checked 2026-10-21
Indexed primary study abstract
Checked 2026-10-21. Labels and commercial information can change.
Gennev: careChecked 2026-11-10
Provider service information
Checked 2026-11-10. Labels and commercial information can change.
Gennev: feesChecked 2026-11-10
Provider pricing
Checked 2026-11-10. Labels and commercial information can change.
Gennev: termsChecked 2026-11-10
Provider terms
Checked 2026-11-10. Labels and commercial information can change.
Gennev: weight careChecked 2026-11-10
Provider service information
Checked 2026-11-10. Labels and commercial information can change.
DailyMed: LynkuetChecked 2026-11-10
Exact product labeling
Checked 2026-11-10. Labels and commercial information can change.
DailyMed: VeozahChecked 2026-11-10
Exact product labeling
Checked 2026-11-10. Labels and commercial information can change.
DailyMed: BrisdelleChecked 2026-11-10
Exact product labeling
Checked 2026-11-10. Labels and commercial information can change.
Newson: feesChecked 2026-11-10
Provider pricing
Checked 2026-11-10. Labels and commercial information can change.
Newson: termsChecked 2026-11-10
Provider terms
Checked 2026-11-10. Labels and commercial information can change.
Newson: consultationsChecked 2026-11-10
Provider service information
Checked 2026-11-10. Labels and commercial information can change.
Evernow: paroxetineChecked 2026-11-10
Provider product information
Checked 2026-11-10. Labels and commercial information can change.
Evernow: VeozahChecked 2026-11-10
Provider product information
Checked 2026-11-10. Labels and commercial information can change.
Evernow: FAQChecked 2026-11-10
Provider service information
Checked 2026-11-10. Labels and commercial information can change.
CoreAge: offerChecked 2026-11-10
Provider product information
Checked 2026-11-10. Labels and commercial information can change.
Midi: feesChecked 2026-11-10
Provider pricing
Checked 2026-11-10. Labels and commercial information can change.